Table 3.
Demographics for FEV1 Decline Groups COPD
| ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
FEV1 decline group | Group 1 n=93
|
Group 2 n=42
|
Group 3 n=59
|
Group 4 n=201
|
Across all groups | Statistic between groups 1 and 4 | ||||||||||||
No decline (decline of <−0.1% predicted per year) | Decline of −0.1 to <−0.5 | Decline of −0.5 to <−1.0 | Decline of at least −1.0 | |||||||||||||||
|
|
|
|
|
||||||||||||||
N | % | Mean | SD | N | % | Mean | SD | N | % | Mean | SD | N | % | Mean | SD | P-value | P-value | |
Never smokers | 19 | 20.4% | 2 | 4.8% | 9 | 15.3% | 52 | 25.9% | 0.013 | 0.311 | ||||||||
Index patient | 85 | 91.4% | 40 | 95.2% | 53 | 89.8% | 175 | 87.1% | 0.382 | 0.280 | ||||||||
Female | 43 | 46.2% | 14 | 33.3% | 20 | 33.9% | 76 | 37.8% | 0.337 | 0.171 | ||||||||
Age | 93 | 54.1 | 8.6 | 42 | 50.6 | 8.0 | 59 | 52.5 | 8.4 | 201 | 53.0 | 10.0 | 0.193 | 0.456 | ||||
FEV1 % predicted | 93 | 50.5 | 24.8 | 42 | 41.5 | 17.2 | 59 | 47.8 | 19.1 | 201 | 58.3 | 20.8 | <0.0001 | <0.0001 | ||||
FVC % predicted | 93 | 107.1 | 24.1 | 42 | 98.1 | 18.4 | 59 | 104.0 | 20.6 | 201 | 114.5 | 21.6 | <0.0001 | 0.004 | ||||
FEV1/FVC | 93 | 37.7 | 13.8 | 42 | 34.3 | 11.6 | 59 | 36.9 | 12.1 | 201 | 41.2 | 12.1 | 0.001 | 0.017 | ||||
DLco % predicted | 61 | 61.3 | 19.7 | 20 | 57.1 | 20.5 | 37 | 62.6 | 17.9 | 132 | 61.8 | 17.3 | 0.722 | 0.788 | ||||
Kco % predicted | 92 | 64.6 | 19.2 | 42 | 62.4 | 19.0 | 59 | 66.2 | 19.1 | 201 | 61.2 | 16.8 | 0.265 | 0.203 | ||||
RV % predicted | 89 | 126.4 | 39.4 | 42 | 147.9 | 48.1 | 57 | 137.5 | 34.5 | 199 | 121.9 | 37.1 | 0.001 | 0.295 | ||||
TLC % predicted | 89 | 116.2 | 14.8 | 42 | 119.2 | 17.7 | 57 | 117.2 | 12.7 | 199 | 117.1 | 15.7 | 0.852 | 0.822 | ||||
RV/TLC | 89 | 37.2 | 8.8 | 42 | 40.3 | 10.1 | 57 | 38.8 | 7.1 | 199 | 34.7 | 8.4 | <0.0001 | 0.010 | ||||
FEV1 slope mL/year | 93 | 11.2 | 32.3 | 42 | −22.4 | 10.6 | 59 | −36.3 | 8.2 | 201 | −86.2 | 54.7 | N/A | N/A | ||||
FEV1 % slope per year | 93 | 0.9 | 1.2 | 42 | −0.3 | 0.1 | 59 | −0.8 | 0.1 | 201 | −2.4 | 1.4 | N/A | N/A | ||||
Kco % slope per year | 89 | −1.3 | 1.8 | 41 | −1.2 | 1.5 | 58 | −1.58 | 1.8 | 189 | −1.5 | 2.2 | 0.709 | 0.730 | ||||
Distribution within Kco decline groups | ||||||||||||||||||
Kco Group 1 | 16 | 18.0% | 10 | 24.4% | 8 | 13.8% | 38 | 20.1% | 0.633 | 0.789 | ||||||||
Kco Group 2 | 8 | 9.0% | 5 | 12.2% | 5 | 8.6% | 12 | 6.3% | ||||||||||
Kco Group 3 | 14 | 15.7% | 5 | 12.2% | 6 | 10.3% | 35 | 18.5% | ||||||||||
Kco Group 4 | 51 | 57.3% | 21 | 51.2% | 39 | 67.2% | 104 | 55.0% |
Notes: TLco is overall gas transfer; Kco is gas transfer corrected for alveolar ventilation. % values indicate the proportion of each group with individual categorical characteristics. Significant P-values are given in bold.
Abbreviations: COPD, chronic obstructive pulmonary disease; FVC, forced vital capacity; FEV1, forced expired volume in 1 second; N/A, not available; SD, standard deviation; RV, residual volume; TLC, total lung capacity.